a double-blind rct of 158 veterans: ketamine significantly reduced ptsd severity scores and extended time to relapse. the research exists. the funded pathway is what is missing.
a 2024 meta-analysis: ketamine produced significant reductions in ptsd, depression, AND chronic pain across military populations. one of the few interventions with evidence for all three.
approximately 30% of ukrainian veterans have ptsd — and diagnoses have been rising sharply since 2021. they need structured, trauma-informed, clinically supervised care.